| Sartaj Singh Sandhu, MD | |
|
680 Cohasset Rd, Chico, CA 95926-2213 | |
| (530) 342-4395 | |
| Not Available |
| Full Name | Sartaj Singh Sandhu |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 680 Cohasset Rd, Chico, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073861654 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | A145527 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health Lodi Memorial | Lodi, CA | Hospital |
| Oroville Hospital | Oroville, CA | Hospital |
| Enloe Medical Center | Chico, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adventist Health Physicians Network | 3274580972 | 499 |
| Ampla Health | 5092619270 | 63 |
News Archive
A new method to create kidney organoids from patient cells may provide insights into how kidney diseases arise and how they should be treated.
In this post in the Public Health Institute's "Dialogue4Health" blog, Jeffrey Meer, director of PHI's Washington-based advocacy on global health, writes that "a significant expansion of PEPFAR's existing work to combat cervical cancer" through a partnership with the George W. Bush Institute known as Pink Ribbon Red Ribbon (PRRR); a 50 percent increase in the U.S. government's "commitment to screen and treat for this type of cancer from $20 million over five years to $30 million"; and additional funding from Susan G. Komen for the Cure "to expand breast cancer awareness and prevention among the same target population of women receiving care at PEPFAR-funded HIV service sites" has allowed "the wonderfully robust PEPFAR prevention and treatment platform, considered one of the great global health achievements in recent times, to be made available to a whole new type of prevention - in this case for a non-communicable disease (NCD)."
News reports examine the speculation, which has already begun, regarding the impact of Sen. Edward Kennedy's passing might have on the current health reform debate.
Dominion Diagnostics (Dominion) has recently developed and validated one of the first clinical quantitative assays for the drug tapentadol (Nucynta(TM)) performed by liquid chromatography/tandem mass spectrometry (LC/MS/MS). Tapentadol, recently approved for use by the FDA, is a centrally-active analgesic that has demonstrated efficacy in pain relief with improved gastrointestinal tolerability compared to other opioids for pain management.
› Verified 3 days ago
| Entity Name | Ampla Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952333635 PECOS PAC ID: 5092619270 Enrollment ID: O20040225001116 |
News Archive
A new method to create kidney organoids from patient cells may provide insights into how kidney diseases arise and how they should be treated.
In this post in the Public Health Institute's "Dialogue4Health" blog, Jeffrey Meer, director of PHI's Washington-based advocacy on global health, writes that "a significant expansion of PEPFAR's existing work to combat cervical cancer" through a partnership with the George W. Bush Institute known as Pink Ribbon Red Ribbon (PRRR); a 50 percent increase in the U.S. government's "commitment to screen and treat for this type of cancer from $20 million over five years to $30 million"; and additional funding from Susan G. Komen for the Cure "to expand breast cancer awareness and prevention among the same target population of women receiving care at PEPFAR-funded HIV service sites" has allowed "the wonderfully robust PEPFAR prevention and treatment platform, considered one of the great global health achievements in recent times, to be made available to a whole new type of prevention - in this case for a non-communicable disease (NCD)."
News reports examine the speculation, which has already begun, regarding the impact of Sen. Edward Kennedy's passing might have on the current health reform debate.
Dominion Diagnostics (Dominion) has recently developed and validated one of the first clinical quantitative assays for the drug tapentadol (Nucynta(TM)) performed by liquid chromatography/tandem mass spectrometry (LC/MS/MS). Tapentadol, recently approved for use by the FDA, is a centrally-active analgesic that has demonstrated efficacy in pain relief with improved gastrointestinal tolerability compared to other opioids for pain management.
› Verified 3 days ago
| Entity Name | Adventist Health Physicians Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063718583 PECOS PAC ID: 3274580972 Enrollment ID: O20050407000633 |
News Archive
A new method to create kidney organoids from patient cells may provide insights into how kidney diseases arise and how they should be treated.
In this post in the Public Health Institute's "Dialogue4Health" blog, Jeffrey Meer, director of PHI's Washington-based advocacy on global health, writes that "a significant expansion of PEPFAR's existing work to combat cervical cancer" through a partnership with the George W. Bush Institute known as Pink Ribbon Red Ribbon (PRRR); a 50 percent increase in the U.S. government's "commitment to screen and treat for this type of cancer from $20 million over five years to $30 million"; and additional funding from Susan G. Komen for the Cure "to expand breast cancer awareness and prevention among the same target population of women receiving care at PEPFAR-funded HIV service sites" has allowed "the wonderfully robust PEPFAR prevention and treatment platform, considered one of the great global health achievements in recent times, to be made available to a whole new type of prevention - in this case for a non-communicable disease (NCD)."
News reports examine the speculation, which has already begun, regarding the impact of Sen. Edward Kennedy's passing might have on the current health reform debate.
Dominion Diagnostics (Dominion) has recently developed and validated one of the first clinical quantitative assays for the drug tapentadol (Nucynta(TM)) performed by liquid chromatography/tandem mass spectrometry (LC/MS/MS). Tapentadol, recently approved for use by the FDA, is a centrally-active analgesic that has demonstrated efficacy in pain relief with improved gastrointestinal tolerability compared to other opioids for pain management.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sartaj Singh Sandhu, MD 680 Cohasset Rd, Chico, CA 95926-2213 Ph: (530) 342-4395 | Sartaj Singh Sandhu, MD 680 Cohasset Rd, Chico, CA 95926-2213 Ph: (530) 342-4395 |
News Archive
A new method to create kidney organoids from patient cells may provide insights into how kidney diseases arise and how they should be treated.
In this post in the Public Health Institute's "Dialogue4Health" blog, Jeffrey Meer, director of PHI's Washington-based advocacy on global health, writes that "a significant expansion of PEPFAR's existing work to combat cervical cancer" through a partnership with the George W. Bush Institute known as Pink Ribbon Red Ribbon (PRRR); a 50 percent increase in the U.S. government's "commitment to screen and treat for this type of cancer from $20 million over five years to $30 million"; and additional funding from Susan G. Komen for the Cure "to expand breast cancer awareness and prevention among the same target population of women receiving care at PEPFAR-funded HIV service sites" has allowed "the wonderfully robust PEPFAR prevention and treatment platform, considered one of the great global health achievements in recent times, to be made available to a whole new type of prevention - in this case for a non-communicable disease (NCD)."
News reports examine the speculation, which has already begun, regarding the impact of Sen. Edward Kennedy's passing might have on the current health reform debate.
Dominion Diagnostics (Dominion) has recently developed and validated one of the first clinical quantitative assays for the drug tapentadol (Nucynta(TM)) performed by liquid chromatography/tandem mass spectrometry (LC/MS/MS). Tapentadol, recently approved for use by the FDA, is a centrally-active analgesic that has demonstrated efficacy in pain relief with improved gastrointestinal tolerability compared to other opioids for pain management.
› Verified 3 days ago
Eric A Ford, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Governors Ln, Chico, CA 95926 Phone: 530-894-8800 Fax: 530-894-8929 | |
Dr. Arthur J Brinckerhoff, M.D. Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 277 Cohasset Rd, Chico, CA 95926 Phone: 530-872-6650 | |
Brian Thomas Courtney, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1531 Esplanade, Chico, CA 95926 Phone: 530-896-7455 Fax: 530-896-1730 | |
Rubens Barros Costa Filho, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 265 Cohasset Rd, Chico, CA 95926 Phone: 530-332-4700 | |
Dr. Leena Singh, MD, PHD Geriatric Medicine Medicare: May Accept Medicare Assignments Practice Location: 1488 East Ave, Suite 130, Chico, CA 95926 Phone: 530-342-1310 | |
Alyssa Milliron, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 680 Cohasset Rd, Chico, CA 95926 Phone: 530-342-4395 Fax: 530-894-2325 | |
Dr. Sam Mazj, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 265 Cohasset Rd, Suite 170, Chico, CA 95926 Phone: 530-893-2323 Fax: 530-894-0935 |